BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35226354)

  • 21. [Molecular Mechanism Underlying the Function and Disintegration of the Central Nerve System Barrier Unraveled by Proteo-typing of Membrane Proteins].
    Terasaki T
    Brain Nerve; 2021 Jan; 73(1):59-78. PubMed ID: 33361514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
    Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
    Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks.
    Uchida Y; Ohtsuki S; Kamiie J; Ohmine K; Iwase R; Terasaki T
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):205-8. PubMed ID: 25770030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat Kidney.
    Uchida Y; Toyohara T; Ohtsuki S; Moriyama Y; Abe T; Terasaki T
    J Pharm Sci; 2016 Feb; 105(2):1011-1016. PubMed ID: 26367854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
    Fallon JK; Smith PC; Xia CQ; Kim MS
    Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.
    Pelkonen L; Sato K; Reinisalo M; Kidron H; Tachikawa M; Watanabe M; Uchida Y; Urtti A; Terasaki T
    Mol Pharm; 2017 Mar; 14(3):605-613. PubMed ID: 28112518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
    Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
    Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
    Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
    Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Proteomics-Based Blood-Brain Barrier Study.
    Uchida Y
    Biol Pharm Bull; 2021; 44(4):465-473. PubMed ID: 33790097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.
    Hoshi Y; Uchida Y; Tachikawa M; Inoue T; Ohtsuki S; Terasaki T
    J Pharm Sci; 2013 Sep; 102(9):3343-55. PubMed ID: 23650139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid.
    Ren G; Qin Z; Yang N; Chen H; Fu K; Lu C; Lu Y; Li N; Zhang Y; Chen X; Zhao D
    Chem Biol Interact; 2020 Jun; 324():109097. PubMed ID: 32305507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse.
    Kido Y; Nanchi I; Fusamae Y; Matsuzaki T; Akazawa T; Sawada H; Iwasaki M; Nishida K; Tsuchiya E; Okuda T
    Drug Metab Pharmacokinet; 2022 Feb; 42():100426. PubMed ID: 34974334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney Cortical Transporter Expression across Species Using Quantitative Proteomics.
    Basit A; Radi Z; Vaidya VS; Karasu M; Prasad B
    Drug Metab Dispos; 2019 Aug; 47(8):802-808. PubMed ID: 31123036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.
    Uchida Y; Ohtsuki S; Katsukura Y; Ikeda C; Suzuki T; Kamiie J; Terasaki T
    J Neurochem; 2011 Apr; 117(2):333-45. PubMed ID: 21291474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
    Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
    Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.
    Feng B; West M; Patel NC; Wager T; Hou X; Johnson J; Tremaine L; Liras J
    J Pharm Sci; 2019 Jul; 108(7):2476-2483. PubMed ID: 30794795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule.
    Jenkinson SE; Chung GW; van Loon E; Bakar NS; Dalzell AM; Brown CD
    Pflugers Arch; 2012 Dec; 464(6):601-11. PubMed ID: 23014881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.